Home
Search:
1146 feeds
357 categories
3086 articles (<24 hours)
25 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsPAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVOTM) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
(World News USA)

 
 

2 july 2020 20:59:43

 
PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVOTM) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
(World News USA)
 


DGAP-News: PAION AG / Key word(s): Regulatory Approval 02.07.2020 / 20:09 The issuer is solely responsible for the content of this announcement. PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVOTM) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION - PAION will receive a milestone payment of EUR 15 million from Cosmo and tiered royalties on net sales ranging from 20% to 25% - Acacia, who will commercialize BYFAVOTM (remimazolam) in the U.S., is planning to launch in the second half of 2020 - Conference call hosted by Acacia scheduled for 9:00 am ET, Monday 6 July 2020 Aachen (Germany), 02 July 2020 - The specialty pharma company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock...


 
38 viewsCategory: General > North America > USA
 
Feds arrest Jeffrey Epstein associate Ghislaine Maxwell, accused of recruiting child sex victims
(World News USA)
PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVO) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
(World News USA)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten